Skip to content
10-K/A

Annual Report

JRSIS HEALTH CARE CORPORATION JRSS

0001213900-23-072794

← back to feed
Filed
Aug 31, 2023 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Aug 31, 2023 58.37M sh
Shares Diluted restated FY 2022 · Dec 31, 2022 44.89M sh
Shares Diluted FY 2022 · Dec 31, 2021 18.66M sh
Capex FY 2022 · Dec 31, 2022 $44.64K
Operating Cash Flow restated FY 2022 · Dec 31, 2022 $3.07M
Operating Cash Flow FY 2022 · Dec 31, 2021 $8.23M
Cash And Equivalents FY 2022 · Dec 31, 2022 $58.62K
Cash And Equivalents restated FY 2022 · Dec 31, 2021 $29.85K
Stockholders Equity restated FY 2022 · Dec 31, 2022 $811.32K
Stockholders Equity FY 2022 · Dec 31, 2021 $22.07M
Current Liabilities restated FY 2022 · Dec 31, 2022 $43.23K
Current Liabilities FY 2022 · Dec 31, 2021 $17.6M
Total Liabilities restated FY 2022 · Dec 31, 2022 $44.66K
Total Liabilities FY 2022 · Dec 31, 2021 $42.59M
Current Assets restated FY 2022 · Dec 31, 2022 $798.85K
Current Assets FY 2022 · Dec 31, 2021 $13.87M
Total Assets restated FY 2022 · Dec 31, 2022 $855.98K
Total Assets FY 2022 · Dec 31, 2021 $75.69M
Eps Diluted restated FY 2022 · Dec 31, 2022 −$0.75
Eps Diluted restated FY 2022 · Dec 31, 2021 $0.17
Eps Basic restated FY 2022 · Dec 31, 2022 −$0.75
Eps Basic restated FY 2022 · Dec 31, 2021 $0.17
Net Income restated FY 2022 · Dec 31, 2022 $2.33M
Net Income FY 2022 · Dec 31, 2021 $3.19M
Operating Income restated FY 2022 · Dec 31, 2022 −$325.89K
Operating Income restated FY 2022 · Dec 31, 2021 −$103.8K
Revenue restated FY 2022 · Dec 31, 2022 $89.17K